Psychological interventions for enhancing adherence to disease-modifying therapies (DMTs) in multiple sclerosis-Reference-Cited by-同舟云学术

Psychological interventions for enhancing adherence to disease-modifying therapies (DMTs) in multiple sclerosis

Published:2016-11-22 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Csillik Antonia¹,Bruce Jared²,Catley Delwyn³,Gay Marie-Claire¹,Goggin Kathleen J⁴,Swaggart Keri R⁵,Thomas Peter W⁶,Thomas Sarah⁶

Affiliation:

1. University of Paris Ouest Nanterre; Department of Psychology; 200, Avenue de la République Nanterre La Dèfense Cedex France F-92001

2. University of Missouri-Kansas City; Department of Psychology; 5030 Cherry Street, Room 313 Kansas City Missouri USA 64110

3. Children's Mercy Hospital & University of Missouri-Kansas City; 2401 Giham Road Kansas City MO USA 64108

4. Children's Mercy Hospital & University of Missouri; Health Services and Outcomes Research & Schools of Medicine and Pharmacy; 2401 Giham Road Kansas City MO USA 64108

5. The Children's Mercy Hospital and Clinics; Library Services; 2401 Gillham Road Kansas City MO USA 64108

6. School of Health and Social Care, Bournemouth University; Bournemouth University, Clinical Research Unit, Faculty of Health and Social Sciences; R506A Royal London House Christchurch Road Bournemouth Dorset UK BH1 3LT

Publisher

Wiley

Subject

Pharmacology (medical)

Reference54 articles.

1. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability;Amato;Multiple Sclerosis (Houndmills, Basingstoke, England),2001

2. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change;Benedict;Journal of Neurological Sciences,2005

3. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis;Berger;Journal of the American Pharmacists Association : JAPhA,2005

4. Contracts between patients and healthcare practitioners for improving patients’ adherence to treatment, prevention and health promotion activities;Bosch-Capblanch;Cochrane Database of Systematic Reviews,2007

5. Objective adherence monitoring in MS: Initial validation and association with self-report;Bruce;Multiple Sclerosis (Houndmills, Basingstoke, England),2010